Between hope and evidence: How community advisors demarcate the boundary between legitimate and illegitimate stem cell treatments
- 2 November 2014
- journal article
- research article
- Published by SAGE Publications in Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine
- Vol. 19 (2) , 188-206
Abstract
Stem cell science provides an exemplary study of the ‘management of hope’. On the one hand, raising ‘hopes’ and expectations is a seen as a necessary aspect of securing investment in promising innovative research. On the other, such hyperbole risks raising hopes to a level that may lead people to undertake undue risks, which may ultimately undermine confidence in medical research. In this context, the ‘management of hope’ thus involves the negotiation of competing claims of truth about the value and safety of particular treatments and about the trustworthiness of providers. Using Gieryn’s concept of boundary-work, this article examines the means by which this work of ‘managing hope’ is undertaken. Drawing on data collected as part of our study that investigated the perspectives of those who are consulted by patients and their carers about stem cell treatments, we explore how these community advisors – both scientists and clinicians with a stake in stem cell research and representatives from patient advocacy groups – demarcate the boundary between legitimate and illegitimate treatments. In particular, we examine how these actors rhetorically use ‘evidence’ to achieve this demarcation. We argue that analysing accounts of how advisors respond to patient enquiries about stem cell treatments offers a window for examining the workings of the politics of hope within contemporary bioscience and biomedicine. In conclusion, we emphasize the need to re-conceptualize the boundary between science and non-science so as to allow a better appreciation of the realities of health care in the age of medical travel.Keywords
This publication has 29 references indexed in Scilit:
- The Promise and Perils of Stem Cell TherapeuticsCell Stem Cell, 2012
- Stem Cell Tourism and the Power of HopeThe American Journal of Bioethics, 2010
- Negotiating the boundary between medicine and consumer culture: Online marketing of nutrigenetic testsSocial Science & Medicine, 2010
- The need to act a little more ‘scientific’: biomedical researchers investigating complementary and alternative medicineSociology of Health & Illness, 2010
- Questioning Hype, Rescuing Hope? The Hwang Stem Cell Scandal and the Reassertion of Hopeful HorizonsScience as Culture, 2008
- “Have You Seen Your Aura Lately?” Examining Boundary-Work in Holistic Health PamphletsQualitative Health Research, 2007
- The Political Economy of Hope: Patients’ Organizations, Science and BiovalueBioSocieties, 2006
- Ethical boundary‐work in the embryonic stem cell laboratorySociology of Health & Illness, 2006
- Shifting Tenses: Reconnecting Regimes of Truth and HopeConfigurations, 2005
- Boundary-Work and the Demarcation of Science from Non-Science: Strains and Interests in Professional Ideologies of ScientistsAmerican Sociological Review, 1983